DARPA aka the USgovt/US mil contracted pfizer/moderna/etc to craft the mrna gene editing technologies in 2013- posted and noted here many times.

>>18416942 (pb)

>>18402860 (pb)

>>18457428 (pb)

>>18457431 (pb)

>>18457444 (pb)

>>13710921 (pb)

>>13710809 (pb)

now lets tie DARPA to the Rockefeller Foundation which scenario'd a pandemic called 'Lock Step' in May 2010

>>19023021 (pb)

>>19023020 (pb)

>>19023041 (pb)

>>19023056 (pb)

>>19023080 (pb)

Here is Rick A. Bright, PhD

https://www.rockefellerfoundation.org/profile/dr-rick-bright/

Rick Bright is formerly the Chief Executive Officer of the Pandemic Prevention Institute (PPI) at The Rockefeller Foundation. Dr. Bright lead the development of the Foundation’s pandemic data-to-action platform that integrates modern technology, data analytics and global partners to help the world detect, prevent, and mitigate pandemic threats to achieve containment as quickly as possible.

Prior to this role, he served as theDeputy Assistant Secretary for Preparedness and Response and the Director of the Biomedical Advanced Research and Development Authority(BARDA), in the U.S. Department of Health and Human Services. Dr. Bright has also gained extensive experience in the biotechnology industry where he served in senior leadership and executive management roles. He has held senior scientific leadership positions in non-governmental organizations where he championed innovative vaccine development and expanded vaccine manufacturing capacity to multiple developing countries. He also spent a decade in vaccine, therapeutics, and diagnostics development at the Centers for Disease Control and Prevention. For this work, Dr. Bright received the Charles C. Shepard Science Award for Scientific Excellence.

Dr. Bright sits on the Executive Board of the New York Academy of Sciences’ International Science Reserve and serves as an international subject matter expert in biodefense, emergency preparedness and response, pharmaceutical innovation, vaccine, drug and diagnostics development. He also served as an advisor to the Biden Administration, World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the National Academies of Sciences, Engineering & Medicine Forum on Microbial Threats. Dr. Bright is a member of the Council on Foreign Relations and serves as a Sr. Fellow at the Foreign Policy Association.

Dr. Bright received a Ph.D. in Immunology and Molecular Pathogenesis from Emory University and a B.S. magna cum laude in Biology and Physical Sciences from Auburn University at Montgomery.

___

In July 2005, at the hearings before the Committee on Health, Education, Labor, and Pensions, the first CEO and Director of the center, Tara O'Toole, MD, MPH, has pointed to center's role as the "BioDARPA" (i.e. "biomedical DARPA").

https://en.wikipedia.org/wiki/Biomedical_Advanced_Research_and_Development_Authority

>>19026686

And here is Victoria Coleman

https://www.rockefellerfoundation.org/profile/victoria-coleman/

Chief Executive Officer, AtlasAI

Victoria Coleman is the CEO of Atlas AI, a public benefit corporation bringing world class AI solutions to sustainable development. She is a member of the Defense Science Board,the Chair of DARPA’s Microsystems Exploratory Council, a Senior Fellow at the Potomac Institute for Policy Studies, a member of Lockheed Martin’s Technology Advisory Group and a member of Santa Clara University’s Advisory Board for the Department of Computer Engineering. She serves as Senior Advisor to the Director of the Center for Information Technology Research in the Interest of Society (CITRIS) at UC Berkeley.

DARPA Successfully Transitions Synthetic Biomanufacturing Technologies to Support National Security Objectives

https://www.darpa.mil/news-events/2021-12-08

Living Foundries: 1000 Molecules program testing and evaluation partners from three military branches to continue advanced technology development

Launched in 2010, DARPA’s Living Foundries program aimed to enable adaptable, scalable, and on-demand production of critical, high-value molecules by programming the fundamental metabolic processes of biological systems to generate a vast number of complex molecules. These molecules were often prohibitively expensive, unable to be domestically sourced, and/or impossible to manufacture using traditional synthetic chemistry approaches. As a proof of concept, DARPA intended to produce 1,000 molecules and material precursors spanning a wide range of defense-relevant applications including industrial chemicals, fuels, coatings, and adhesives.

Divided into two parts – Advanced Tools and Capabilities for Generalizable Platforms (ATCG) and 1000 Molecules – the Living Foundries program succeeded not only in meeting its programmatic goals of producing 1000 molecules as a proof-of-concept, but pivoted in 2019 to expand program objectives to working with military mission partners to test molecules for military applications. The performer teams collectively have produced over 1630 molecules and materials to-date, and more importantly, DARPA is transitioning a subset of these technologies to five military research teams from Army, Navy, and Air Force labs who partnered with the agency on testing and evaluation over the course of the program.

“Biologically-produced molecules offer orders-of-magnitude greater diversity in chemical functionality compared to traditional approaches, enabling scientists to produce new bioreachable molecules faster than ever before,” noted Dr. Anne Cheever, Living Foundries program manager. “Through Living Foundries, DARPA has transformed synthetic biomanufacturing into a predictable engineering practice supportive of a broad range of national security objectives.”

The Living Foundries teams used a range of technologies and strategies to address significant synthetic biology challenges as outlined below:

The Naval Air Warfare Center Weapons Division (NAWCWD) team led by Dr. Ben Harvey in collaboration with Amyris, Inc. and Zymergen developed tools and technologies for producing high-performance chemicals and materials useful in a variety of military applications. NAWCWD converted precursor molecules into high energy density fuels, energetic materials, thermostable polymers, and high-performance composites. These technologies will be further developed through the Office of Naval Research (ONR) Bioengineering and Biomanufacturing Program, the ONR Advanced Energetics Manufacturing Pipeline, The Wright Brothers Institute/AFRL Synthetic Biology Challenge, and the Bioindustrial Manufacturing and Design Ecosystem (BioMADE).

United States Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) team (Drs. Greg Peterson, Jared DeCoste, and Vipin Rastogi) are developing filters, fabrics, and decontaminating wipes to combat chemical and biological weapons agents using biologically templated materials from the Massachusetts Institute of Technology. This technology will undergo further testing and development at DEVCOM CBC as part of the Defense Threat Reduction Agency multifunctional material program.

Air Force Research Laboratory’s Materials and Manufacturing Directorate (AFRL RX) team, led by Drs. Nick Godman and Tod Grusenmeyer, produced laser eye protection goggles using bio-derived molecules developed by Zymergen. This technology will be transferred to the Personnel Protection Team in AFRL RX for testing and evaluation.

AFRL Aerospace Systems Directorate (AFRL RQ) team (Drs. Oscar Ruiz, Don Phelps, and Paul Wrzesinski) is testing fuels developed by NAWCWD using biologically produced molecules from Amyris, Inc. for use in military aircraft and will work with the Navy on additional development efforts.

DEVCOM Army Research Laboratory team (Drs. Joshua Orlicki, Anthony Clay, John La Scala, and Robert Jensen) formulated adhesives for evaluation to potentially attach armor to vehicles and polymers for 3D printing applications using technologies developed by Amyris and Zymergen. ARL will continue development of these technologies.

“Several biologically produced molecules within the 1000 Molecules Program have intriguing molecular characteristics for development of advanced polymers,” noted John La Scala, Chief of the Manufacturing Sciences and Technology Branch at DEVCOM Army Research Laboratory. “These unique compounds have potential for use in durable adhesives for armor and other ground vehicle structural applications and high-performance composites for aircraft and missile applications.”

p1

>>19026711

All of these technologies transitioned to the military branch they support, and at least one spin-off company has been launched for bio-templated materials for batteries and chemical filtration. Additional industrial partnerships are still being considered in the areas of sustainable fuels, marine epoxies, electronic composites, adhesives and coatings, among others.

“Capability delivery is fundamentally a team sport,” said Rear Adm. Scott Dillon, Naval Air Warfare Center Weapons Division commander, “and we need diverse and capable teams from government partners like DARPA, industry, and academic collaborators to ensure our warfighters have the decisive advantage. I’m excited to see where our future partnerships will take us.”

# # #

2 of 2

>>19026711

>>19026712

DARPA and the Brain Initiative

https://www.darpa.mil/program/our-research/darpa-and-the-brain-initiative

The White House announced the BRAIN initiative in April 2013. Today, the initiative is supported by several federal agencies as well as dozens of technology firms, academic institutions, scientists and other key contributors to the field of neuroscience. DARPA is supporting the BRAIN initiative through a number of programs, continuing a legacy of DARPA investment in neurotechnology that extends back to the 1970s. An article in our 60th anniversary magazine provides an overview of the agency's recent research aimed at expanding the frontiers of the field and enabling powerful, new capabilities.

Electrical Prescriptions (ElectRx)

The ElectRx program aims to help the human body heal itself through neuromodulation of organ functions using ultraminiaturized devices, approximately the size of individual nerve fibers, which could be delivered through minimally invasive injection.

Work Begins to Support Self-Healing of Body and Mind

ElectRx Has the Nerve to Envision Revolutionary Therapies for Self-Healing

President Obama Highlights New DARPA Program Aimed at Developing Novel Therapies Customized to Individual Patients

Hand Proprioception and Touch Interfaces (HAPTIX)

The HAPTIX program aims to create fully implantable, modular and reconfigurable neural-interface microsystems that communicate wirelessly with external modules, such as a prosthesis interface link, to deliver naturalistic sensations to amputees.

Neuroscience of Touch Supports Improved Robotic and Prosthetic Interfaces

HAPTIX Starts Work to Provide Prosthetic Hands with Sense of Touch

By Restoring Sense of Touch to Amputees, HAPTIX Seeks to Overcome Physical and Psychological Effects of Upper Limb Loss

Neural Engineering System Design (NESD)

The NESD program aims to develop an implantable neural interface able to provide unprecedented signal resolution and data-transfer bandwidth between the brain and the digital world.

Towards a High-Resolution, Implantable Neural Interface

Bridging the Bio-Electronic Divide

Neuro Function, Activity, Structure and Technology (Neuro-FAST)

The Neuro-FAST program seeks to enable unprecedented visualization and decoding of brain activity to better characterize and mitigate threats to the human brain, as well as facilitate development of brain-in-the loop systems to accelerate and improve functional behaviors. The program has developed CLARITY, a revolutionary tissue-preservation method, and builds off recent discoveries in genetics, optical recordings and brain-computer interfaces.

Researchers Identify Conductor of Brain’s Neural Orchestra & Begin to Decode the Score

Advanced CLARITY Method Offers Faster, Better Views of Entire Brain

Next-Generation Nonsurgical Neurotechnology (N3)

The N3 program aims to develop a safe, portable neural interface system capable of reading from and writing to multiple points in the brain at once. Whereas the most advanced existing neurotechnology requires surgical implantation of electrodes, N3 is pursuing high-resolution technology that works without the requirement for surgery so that it can be used by able-bodied people.

Six Paths to the Nonsurgical Future of Brain-Machine Interfaces

Nonsurgical Neural Interfaces Could Significantly Expand Use of Neurotechnology

Reliable Neural-Interface Technology (RE-NET) (Archived)

The RE-NET program seeks to develop the technologies needed to reliably extract information from the nervous system, and to do so at a scale and rate necessary to control complex machines, such as high-performance prosthetic limbs.

Minimally Invasive “Stentrode” Shows Potential as Neural Interface for Brain

Atom-width Graphene Sensors Could Provide Unprecedented Insights into Brain Structure and Function

New Nerve and Muscle Interfaces Aid Wounded Warrior Amputees

p1

>>19026716

Restoring Active Memory (RAM)

The RAM program aims to develop and test a wireless, fully implantable neural-interface medical device for human clinical use. The device would facilitate the formation of new memories and retrieval of existing ones in individuals who have lost these capacities as a result of traumatic brain injury or neurological disease.

Progress in Quest to Develop a Human Memory Prosthesis

Targeted Electrical Stimulation of the Brain Shows Promise as a Memory Aid

Restoring Active Memory Program Poised to Launch

Restoring Active Memory – Replay (RAM Replay)

The RAM Replay program will investigate the role of neural “replay” in the formation and recall of memory, with the goal of helping individuals better remember specific episodic events and learned skills. The program aims to develop novel and rigorous computational methods to help investigators determine not only which brain components matter in memory formation and recall, but also how much they matter.

DARPA Aims to Accelerate Memory Function for Skill Learning

Revolutionizing Prosthetics

The Revolutionizing Prosthetics program aims to continue increasing functionality of DARPA-developed arm systems to benefit Service members and others who have lost upper limbs. The dexterous hand capabilities developed under the program have already been applied to small robotic systems used to manipulate unexploded ordnance, reducing the risk of limb loss among Soldiers.

DARPA Helps Paralyzed Man Feel Again Using a Brain-Controlled Robotic Arm

Neurotechnology Provides Near-Natural Sense of Touch

From Idea to Market in Eight Years, DARPA-Funded DEKA Arm System Earns FDA Approval

Systems-Based Neurotechnology for Emerging Therapies (SUBNETS)

The SUBNETS program seeks to create implanted, closed-loop diagnostic and therapeutic systems for treating neuropsychological illnesses.

Breakthroughs Inspire Hope for Treating Intractable Mood Disorders

Journey of Discovery Starts toward Understanding and Treating Networks of the Brain

SUBNETS Aims for Systems-Based Neurotechnology and Understanding for the Treatment of Neuropsychological Illnesses

Targeted Neuroplasticity Training (TNT)

The TNT program seeks to advance the pace and effectiveness of cognitive skills training through the precise activation of peripheral nerves that can in turn promote and strengthen neuronal connections in the brain. TNT will pursue development of a platform technology to enhance learning of a wide range of cognitive skills, with a goal of reducing the cost and duration of the Defense Department’s extensive training regimen, while improving outcomes.

TNT Researchers Set Out to Advance Pace and Effectiveness of Cognitive Skills Training

Boosting Synaptic Plasticity to Accelerate Learning

2 of 2

>>19026877

Trump did not mention Neuralink in that list…

curious.